Lamond Capital Partners LLC
Follow13F filer, CIK 1542550, SAN FRANCISCO, CA
Lamond Capital Partners LLC reported $133,620,000 across 10 holdings for the quarter ended 2015-09-30, in a 13F-HR filed 2015-11-09.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001542550-15-000005
- Period
- 2015-09-30
- Reported value
- $134M
- Holdings
- 10
- Top 10 weight
- 100%
- New
- 7
- Sold out
- 8
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| GW PHARMACEUTICALS PLCnew | +120,000 | $11M |
| BMRNnew | +100,000 | $10.5M |
| CYPRESS SEMICONDUCTOR CORPnew | +1,100,000 | $9.37M |
| OCULadded | +521,752 | $7.34M |
| ALEXION PHARMACEUTICALS INCadded | +43,390 | $6.79M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| AXOVANT SCIENCES LTDexited | -692,961 | -$14.1M |
| HEWLETT PACKARD COexited | -337,000 | -$10.1M |
| VIOLIN MEMORY Iexited | -3,934,580 | -$9.64M |
| HORNBECK OFFSHORE SVCS INC Nexited | -352,720 | -$7.24M |
| KITE PHARMA INCexited | -105,498 | -$6.43M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2015
Share positions as resolved from 13F-HR 0001542550-15-000005, largest first. % of portfolio is the value over $77,679,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| OCULOCULAR THERAPEUTIX INC | 1,233,285 | $17.3M | 22.32% | +521,752 | Timeline | ||
| ALEXION PHARMACEUTICALS INCALEXION PHARMACEUTICALS INC | 100,000 | $15.6M | 20.13% | +43,390 | |||
| AMGNAMGEN INC | 100,000 | $13.8M | 17.81% | +3,370 | Timeline | ||
| GW PHARMACEUTICALS PLCGW PHARMACEUTICALS PLC | 120,000 | $11M | 14.11% | new | |||
| BMRNBIOMARIN PHARMACEUTICAL INC | 100,000 | $10.5M | 13.56% | new | Timeline | ||
| CYPRESS SEMICONDUCTOR CORPCYPRESS SEMICONDUCTOR CORP | 1,100,000 | $9.37M | 12.07% | new |
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| AMGNAMGEN INC COM | call | 150,000 | $20.7M | new |
| ORCLORACLE CORP COM | call | 500,000 | $18.1M | new |
| ABBVABBVIE INC COM | call | 250,000 | $13.6M | new |
| KITE PHARMA INCKITE PHARMA INC COM | call | 63,400 | $3.53M | new |
Sold out in Q3 2015
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| AXOVANT SCIENCES LTDAXOVANT SCIENCES LTD | 692,961 | $14.1M | shares |
| HEWLETT PACKARD COHEWLETT PACKARD CO | 337,000 | $10.1M | shares |
| VIOLIN MEMORY IVIOLIN MEMORY I | 3,934,580 | $9.64M | shares |
| HORNBECK OFFSHORE SVCS INC NHORNBECK OFFSHORE SVCS INC N | 352,720 | $7.24M | shares |
| KITE PHARMA INCKITE PHARMA INC | 105,498 | $6.43M | shares |
| INFOBLOX INCINFOBLOX INC | 230,872 | $6.05M | shares |
| NIVALIS THERAPEUTICS INCNIVALIS THERAPEUTICS INC | 225,000 | $3.41M | shares |
| BELLICUM PHARMACEUTICALS INCBELLICUM PHARMACEUTICALS INC | 68,780 | $1.46M | shares |
How Q3 2015 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001542550-15-000005 | base | 2015-11-09 | acceptance time not in the bulk data set |